Moreover, plasma leptin levels are increased in obese type 2 diabetes patients, significantly post-LSG, which indicates the potential of LSG in modifying the conditions of type 2 diabetes by reducing the level of leptin (33). The gene discussed is LEP; the disease is type 2 diabetes mellitus.